Berko Pharmaceuticals Receives COVID-19 Safe Production Center Certificate

20/11/2020

Berko Pharmaceuticals Receives COVID-19 Safe Production Center Certificate

Berko Pharmaceuticals has been entitled to receive the “COVID-19 Safe Production Center Certificate” issued by the Turkish Standards Institute (TSI), thanks to the measures taken by it and the applications implemented in the plant, field and head office from the very beginning of the COVID-19 process.

Berko Pharmaceuticals, having worked and produced for public health for more than thirty-five years, with the vision of “For Healthy Tomorrows”, has been entitled by the to receive the “COVID-19 Safe Production Center Certificate” issued by the Turkish Standards Institute (TSI) thanks to the measures taken by it in both the production and work sites, the utmost hygiene measures it has performed for the employees as well as its applications paying regard to its stakeholders starting from the period when the worldwide-threatening COVID-19 pandemic was started to be seen in our country.

Making a statement about the subject, Berko Pharmaceuticals General Manager Pharmacist Barış Özyurtlu expressed that they had successfully passed the audits of the Turkish Standards Institute and have been entitled to receive the “Safe Production Center Certificate” and that hygiene and safety had always been their utmost priority in the production facilities not only during the COVID-19 period but at all times as per the GMP (Good Manufacturing Practice) standards. Özyurtlu added that they took pride in proving once again the sensitivity Berko İlaç has shown to the public health in order to attain “Healthy Tomorrows” within the framework of the mission Berko İlaç has assigned to their side.

Press Releases